465 related articles for article (PubMed ID: 15857703)
21. Cortical cholinergic deficiency enhances amphetamine-induced dopamine release in the accumbens but not striatum.
Mattsson A; Olson L; Svensson TH; Schilström B
Exp Neurol; 2007 Nov; 208(1):73-9. PubMed ID: 17714706
[TBL] [Abstract][Full Text] [Related]
22. Changes in cholecystokinin receptor binding in rat brain after selective damage of locus coeruleus projections by DSP-4 treatment.
Harro J; Jossan SS; Oreland L
Naunyn Schmiedebergs Arch Pharmacol; 1992 Oct; 346(4):425-31. PubMed ID: 1436127
[TBL] [Abstract][Full Text] [Related]
23. Effect of lead exposure on dopaminergic transmission in the rat brain.
NourEddine D; Miloud S; Abdelkader A
Toxicology; 2005 Feb; 207(3):363-8. PubMed ID: 15664264
[TBL] [Abstract][Full Text] [Related]
24. Effects of SKF-38393, a dopamine D1 receptor agonist on expression of amphetamine-induced behavioral sensitization and expression of immediate early gene arc in prefrontal cortex of rats.
Moro H; Sato H; Ida I; Oshima A; Sakurai N; Shihara N; Horikawa Y; Mikuni M
Pharmacol Biochem Behav; 2007 May; 87(1):56-64. PubMed ID: 17499349
[TBL] [Abstract][Full Text] [Related]
25. Effects of partial locus coeruleus denervation and chronic mild stress on behaviour and monoamine neurochemistry in the rat.
Häidkind R; Eller M; Harro M; Kask A; Rinken A; Oreland L; Harro J
Eur Neuropsychopharmacol; 2003 Jan; 13(1):19-28. PubMed ID: 12480118
[TBL] [Abstract][Full Text] [Related]
26. The role of dopamine D4 receptor in the induction of behavioral sensitization to amphetamine and accompanying biochemical and molecular adaptations.
Feldpausch DL; Needham LM; Stone MP; Althaus JS; Yamamoto BK; Svensson KA; Merchant KM
J Pharmacol Exp Ther; 1998 Jul; 286(1):497-508. PubMed ID: 9655895
[TBL] [Abstract][Full Text] [Related]
27. Electroencephalographic study of the effect of neurotoxin DSP-4 in iron model of chronic focal epilepsy.
Sharma V; Singh R
Indian J Exp Biol; 1999 May; 37(5):468-75. PubMed ID: 10492619
[TBL] [Abstract][Full Text] [Related]
28. Enhanced apomorphine sensitivity and increased binding of dopamine D2 receptors in nucleus accumbens in prepubertal rats after neonatal blockade of the dopamine D3 receptors by (+)-S14297.
Flores-Tochihuitl J; Vargas G; Morales-Medina JC; Rivera G; De La Cruz F; Zamudio S; Flores G
Synapse; 2008 Jan; 62(1):40-9. PubMed ID: 17957737
[TBL] [Abstract][Full Text] [Related]
29. Differential effects of a small, unilateral, 6-hydroxydopamine-induced nigral lesion on behavior in high and low responders to novelty.
van Oosten RV; Cools AR
Exp Neurol; 2002 Feb; 173(2):245-55. PubMed ID: 11822888
[TBL] [Abstract][Full Text] [Related]
30. Behavioral and neurochemical consequences of multiple MDMA administrations in the rat: role of individual differences in anxiety-related behavior.
Ludwig V; Mihov Y; Schwarting RK
Behav Brain Res; 2008 May; 189(1):52-64. PubMed ID: 18241937
[TBL] [Abstract][Full Text] [Related]
31. S33138 [N-[4-[2-[(3aS,9bR)-8-cyano-1,3a,4,9b-tetrahydro[1]-benzopyrano[3,4-c]pyrrol-2(3H)-yl)-ethyl]phenylacetamide], a preferential dopamine D3 versus D2 receptor antagonist and potential antipsychotic agent. II. A neurochemical, electrophysiological and behavioral characterization in vivo.
Millan MJ; Svenningsson P; Ashby CR; Hill M; Egeland M; Dekeyne A; Brocco M; Di Cara B; Lejeune F; Thomasson N; Munoz C; Mocaër E; Crossman A; Cistarelli L; Girardon S; Iob L; Veiga S; Gobert A
J Pharmacol Exp Ther; 2008 Feb; 324(2):600-11. PubMed ID: 18024787
[TBL] [Abstract][Full Text] [Related]
32. Neurochemical mechanisms involved in behavioral effects of amphetamines and related designer drugs.
Gold LH; Geyer MA; Koob GF
NIDA Res Monogr; 1989; 94():101-26. PubMed ID: 2514360
[TBL] [Abstract][Full Text] [Related]
33. Dopamine transporter, but not tyrosine hydroxylase, may be implicated in determining individual differences in behavioral sensitization to amphetamine.
Dietz DM; Tapocik J; Gaval-Cruz M; Kabbaj M
Physiol Behav; 2005 Oct; 86(3):347-55. PubMed ID: 16126238
[TBL] [Abstract][Full Text] [Related]
34. The psychogenetically selected Roman rat lines differ in the susceptibility to develop amphetamine sensitization.
Corda MG; Piras G; Lecca D; Fernández-Teruel A; Driscoll P; Giorgi O
Behav Brain Res; 2005 Feb; 157(1):147-56. PubMed ID: 15617781
[TBL] [Abstract][Full Text] [Related]
35. Activating effects of chronic variable stress in rats with different exploratory activity: association with dopamine d(1) receptor function in nucleus accumbens.
Matrov D; Vonk A; Herm L; Rinken A; Harro J
Neuropsychobiology; 2011; 64(2):110-22. PubMed ID: 21701229
[TBL] [Abstract][Full Text] [Related]
36. Noradrenergic inputs from locus coeruleus to posterior ventral tegmental area are essential to support ethanol reinforcement.
Shelkar GP; Kumar S; Singru PS; Subhedar NK; Kokare DM
Addict Biol; 2017 Mar; 22(2):291-302. PubMed ID: 26549324
[TBL] [Abstract][Full Text] [Related]
37. Differential effects of amphetamine transport vs. dopamine reverse transport on particulate PKC activity in striatal synaptoneurosomes.
Giambalvo CT
Synapse; 2003 Aug; 49(2):125-33. PubMed ID: 12740868
[TBL] [Abstract][Full Text] [Related]
38. The antidepressant-like effect of vagus nerve stimulation is mediated through the locus coeruleus.
Grimonprez A; Raedt R; Portelli J; Dauwe I; Larsen LE; Bouckaert C; Delbeke J; Carrette E; Meurs A; De Herdt V; Boon P; Vonck K
J Psychiatr Res; 2015 Sep; 68():1-7. PubMed ID: 26228393
[TBL] [Abstract][Full Text] [Related]
39. The influence of acute and chronic administration of 1,2-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline on the function of the nigrostriatal dopaminergic system in rats.
Lorenc-Koci E; Antkiewicz-Michaluk L; Kamińska A; Lenda T; Zieba B; Wierońska J; Smiałowska M; Schulze G; Rommelspacher H
Neuroscience; 2008 Oct; 156(4):973-86. PubMed ID: 18809471
[TBL] [Abstract][Full Text] [Related]
40. Modulation by group I mGLU receptor activation and group III mGLU receptor blockade of locomotor responses induced by D1-like and D2-like receptor agonists in the nucleus accumbens.
Rouillon C; Degoulet M; Chevallier K; Abraini JH; David HN
Brain Res; 2008 Mar; 1198():44-54. PubMed ID: 18261716
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
